. 2016 Mar 14;7(16):22234–22244. doi: 10.18632/oncotarget.8067

Table 3. Correlation of FGFR1 protein expression with clinicopathological characteristics in 63 MPNST patients.

Clinical characteristics	Frequency	FGFR1				Clinical characteristics	Frequency	FGFR1
Clinical characteristics	Frequency	++/+++	–/+	χ²	P	Clinical characteristics	Frequency	++/+++	–/+	χ²	P
Gender						AJCC stage
male	34	11	23	0.169	0.681	1	7	2	5	0.571	0.948
female	29	8	21	0.169	0.681	2	32	11	21
Age						3	9	2	7
≥ 40 year	39	10	29	0.992	0.319	4	12	4	8
< 40 year	24	9	15	0.992	0.319	Radiotherapy
Age						yes	25	7	18	0.189	0.664
≥ 30 year	49	16	33	0.651	0.42	no	33	11	22	0.189	0.664
< 30 year	14	3	11	0.651	0.42	Chemotherapy
NF1 type						yes	25	6	19	0.598	0.439
no	58	17	41	0.25	0.617	no	33	11	22	0.598	0.439
yes	5	2	3	0.25	0.617	Recurrence
Tumor site						yes	39	11	28	0.185	0.667
head and neck	10	2	8	4.58	0.101	no	24	8	16	0.185	0.667
trunk	26	5	21			Metastasis
extremity	27	12	15			yes	25	7	18	0.092	0.762
Tumor size						no	38	12	26	0.092	0.762
≤ 5 cm	24	8	16	0.202	0.904
5–10 cm	22	6	16
10 cm	16	5	11